ATE272717T1 - Verfahren zum screening von antibakteriellen mitteln - Google Patents

Verfahren zum screening von antibakteriellen mitteln

Info

Publication number
ATE272717T1
ATE272717T1 AT99954191T AT99954191T ATE272717T1 AT E272717 T1 ATE272717 T1 AT E272717T1 AT 99954191 T AT99954191 T AT 99954191T AT 99954191 T AT99954191 T AT 99954191T AT E272717 T1 ATE272717 T1 AT E272717T1
Authority
AT
Austria
Prior art keywords
antibacterial agents
subpopulation
identified
bacteria
stationary phase
Prior art date
Application number
AT99954191T
Other languages
English (en)
Inventor
Anthony Robert Milnes Coates
Yanmin Hu
Original Assignee
Helperby Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824553.3A external-priority patent/GB9824553D0/en
Priority claimed from GBGB9909962.4A external-priority patent/GB9909962D0/en
Application filed by Helperby Therapeutics Ltd filed Critical Helperby Therapeutics Ltd
Application granted granted Critical
Publication of ATE272717T1 publication Critical patent/ATE272717T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
AT99954191T 1998-11-09 1999-11-09 Verfahren zum screening von antibakteriellen mitteln ATE272717T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10765598P 1998-11-09 1998-11-09
GBGB9824553.3A GB9824553D0 (en) 1998-11-09 1998-11-09 Improvements in or relating to screening antibacterial agents
GBGB9909962.4A GB9909962D0 (en) 1999-04-29 1999-04-29 Improvemments in or relating to screening antibacterial agents
PCT/GB1999/003728 WO2000028074A1 (en) 1998-11-09 1999-11-09 Screening process for antibacterial agents

Publications (1)

Publication Number Publication Date
ATE272717T1 true ATE272717T1 (de) 2004-08-15

Family

ID=27269546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99954191T ATE272717T1 (de) 1998-11-09 1999-11-09 Verfahren zum screening von antibakteriellen mitteln

Country Status (10)

Country Link
US (3) US20020031819A1 (de)
EP (1) EP1129212B1 (de)
JP (1) JP3737365B2 (de)
AT (1) ATE272717T1 (de)
AU (1) AU1061100A (de)
DE (1) DE69919196T2 (de)
DK (1) DK1129212T3 (de)
ES (1) ES2229780T3 (de)
PT (1) PT1129212E (de)
WO (1) WO2000028074A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982153B1 (en) * 1998-12-03 2006-01-03 Targanta Therapeutics, Inc. DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides
GB0522715D0 (en) 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use
US20080220465A1 (en) * 2007-03-05 2008-09-11 Pocared Diagnostics, Inc. Antibiotic Sensitivity Testing Method
HUE041512T2 (hu) 2010-03-30 2019-05-28 Helperby Therapeutics Ltd Új kombináció és alkalmazás
WO2011160048A2 (en) * 2010-06-17 2011-12-22 The Johns Hopkins University Methods of identifying therapeutic agents for treating persister and bacterial infection
DK2600869T3 (da) 2010-08-05 2020-11-16 Helperby Therapeutics Ltd Kombination af en pyrroloquinolinforbindelse og et beta-lactam-antimikrobielt middel, mupirocin eller chlorhexidin
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
HUE052575T2 (hu) 2014-12-18 2021-05-28 Helperby Therapeutics Ltd Új kombináció és alkalmazás
JP6804096B2 (ja) 2015-04-11 2020-12-23 ヘルパービー セラピューティクス リミテッドHelperby Therapeutics Limited 口腔用組成物
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
GB201521771D0 (en) 2015-12-10 2016-01-27 Helperby Therapeutics Ltd Formulation
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201612093D0 (en) 2016-07-12 2016-08-24 Helperby Therapeutics Ltd Combination
GB201616014D0 (en) 2016-09-20 2016-11-02 Helperby Therapeutics Ltd Combination
GB201616909D0 (en) 2016-10-05 2016-11-16 Helperby Therapeutics Ltd Combination
GB201703898D0 (en) 2017-03-10 2017-04-26 Helperby Therapeautics Ltd Method
GB201704620D0 (en) 2017-03-23 2017-05-10 Helperby Therapeautics Ltd Combinations
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
GB201807046D0 (en) 2018-04-30 2018-06-13 Helperby Therapeutics Ltd Combination
GB2589286A (en) * 2019-07-22 2021-06-02 Helperby Therapeutics Ltd Method
GB201913068D0 (en) 2019-09-10 2019-10-23 Helperby Therapeutics Ltd Combination
GB201914847D0 (en) 2019-10-14 2019-11-27 Helperby Therapeutics Ltd Combination
GB202213750D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial
GB202213753D0 (en) 2022-09-20 2022-11-02 Helperby Therapeutics Ltd Antimicrobial combinations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697648A (en) * 1968-05-24 1972-10-10 Meiji Seika Ltd Kk Antibiotic sf-767-a and sf767-l substances,and process for producing same culturing a certain streptomyces microsporeus
US3963576A (en) 1975-02-21 1976-06-15 General Environmental Science Corporation Method for rendering bacteria dormant and the product produced thereby
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
US5670350A (en) * 1990-08-20 1997-09-23 Novartis Finance Corporation Genomic DNA encoding a pseudomonas global transcriptional activation element and its use in activating gene expression
US5684144A (en) * 1993-07-28 1997-11-04 University Of North Texas Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
US5712095A (en) * 1994-06-16 1998-01-27 Becton Dickinson And Company Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors
US5733774A (en) * 1995-02-02 1998-03-31 Ecoscience Corporation Method and composition for producing stable bacteria and bacterial formulations
US5700925A (en) * 1996-03-27 1997-12-23 The Johns Hopkins University DNA encoding stationary phase, stress response sigma factor from Mycobacterium tuberculosis
US6890526B2 (en) * 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US5963576A (en) * 1997-08-04 1999-10-05 Motorola, Inc. Annular waveguide vertical cavity surface emitting laser and method of fabrication

Also Published As

Publication number Publication date
JP2002529103A (ja) 2002-09-10
ES2229780T3 (es) 2005-04-16
EP1129212B1 (de) 2004-08-04
DE69919196D1 (de) 2004-09-09
DE69919196T2 (de) 2005-08-04
EP1129212A1 (de) 2001-09-05
PT1129212E (pt) 2004-11-30
US7892782B2 (en) 2011-02-22
DK1129212T3 (da) 2004-11-22
US20020031819A1 (en) 2002-03-14
JP3737365B2 (ja) 2006-01-18
AU1061100A (en) 2000-05-29
US20050019892A1 (en) 2005-01-27
WO2000028074A1 (en) 2000-05-18
US20090104651A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
DE69919196D1 (de) Verfahren zum screening von antibakteriellen mitteln
EP0885958A4 (de) Methode zur behandlung von biopolymeren, mikroorganismen oder anderen materialien, die mehr als einen typ von magnetischen partikeln benutzt.
DE59703208D1 (de) Verfahren zum Herstellen von SiC durch CVD mit verbesserter Gasausnutzung
DE58903736D1 (de) Verfahren zur behandlung von biomassen, z.b. klaerschlaemmen, guelle, usw.
DE60041770D1 (de) Bifidobacteria zum vorbeugen von diarrhöe infolge pathogener bakterien
DE69722771D1 (de) Verfahren zum nachweis der enzymaktivität von mikroorganismen
DE60129556D1 (de) Verfahren zur fleisch verarbeitung und zum bearbeiten von informationen
DE69935436D1 (de) Verfahren zum nachweis von mikroorganismen
DE59201253D1 (de) Verfahren zum, insbesondere beschleunigten, aeroben mikrobiologischen Abbau von biologischen Substanzen.
ATE253037T1 (de) Verfahren zur racematspaltung von tramadol
EE200200279A (et) Kõdundamise meetod
ATE333903T1 (de) Verfahren zum auffinden von verbindungen zur vorbeugung von infektion oder pathogenizität
ATE247349T1 (de) Verfahren zum etablieren eines gemeinsamen kryptografischen schüssels für n teilnehmer
ATE213782T1 (de) Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate
ATE277887T1 (de) Verfahren zur herstellung von 1,4-bis((2- (dimethylamino)ethyl amino)-5,8- dihydroxyanthracene-9,10-dion
ATE225859T1 (de) Nachweis von antibiotikumresistenzen in mikroorganismen
DE60003807D1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ATE248807T1 (de) Verfahren zur herstellung von n-hydrocarbyl- substituierten amiden
DE59703115D1 (de) Verfahren zum beschichten von dauerwürsten und hartkäsen
DE59006538D1 (de) Verfahren zum Aufarbeiten von sauren Fe-haltigen Lösungen, insbesondere Abfallbeizlösungen.
DE69011525D1 (de) Verfahren zur bekämpfung von mikroorganismen.
DE69512378T2 (de) Verfahren zur entfernung von unerwünschten farben aus salzsäure
BR0317351A (pt) Ativador orgânico, processo para a produção, composição de limpeza e método de limpeza do mesmo
DE59814284D1 (de) Nucleinsäure-sequenzen und verfahren zum nachweis
DE69019631D1 (de) Verfahren zum Schützen und Konservieren von Mikroorganismen, insbesondere von Bakterien.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1129212

Country of ref document: EP